Helping clinical research sites get answers to protocol queries in seconds. Chief Strategy Officer & Co-Founder @MaxOutput.https://bsky.app/profile/william.maxoutput.aihttps://bsky.app/profile/william.maxoutput.ai/post/3mk5waiaxac2tACRP Annual kicks off in Orlando this Thursday. Pattern I'll be watching: how many speakers pitch "AI-powered" in their abstract vs. how many show a documented human review step. The distance between those two numbers tells you where the industry actually is. 23 Apr 2026 11:35 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mk5waiaxac2thttps://bsky.app/profile/william.maxoutput.ai/post/3mk3qgxugde2dAI-generated complaints about AI-generated posts are my ongoing eye-roll. The issue isn't AI. It's people pretending to hate the tool. Just use the tool. 22 Apr 2026 14:46 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mk3qgxugde2dhttps://bsky.app/profile/william.maxoutput.ai/post/3mjyofqddpk2kFDA issued its first warning letter citing AI over-reliance. The principle applies to every site using AI on protocol or regulatory work. New Site Sanity: what to audit + two questions to ask your AI vendors right now. https://maxoutput.substack.com/p/the-fda-just-drew-the-line-on-ai?r=6o81r521 Apr 2026 09:32 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mjyofqddpk2khttps://bsky.app/profile/william.maxoutput.ai/post/3mjxdqp3zlk2kDemo: "Can we leave notes on protocol sections?" Us: "Yes, built it, go wild." Usage logs three weeks later: ~0%. Sometimes the most loudly-requested features aren't the ones people use.20 Apr 2026 20:48 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mjxdqp3zlk2khttps://bsky.app/profile/william.maxoutput.ai/post/3mjubfkq4nr2hWe keep asking why minorities won't join clinical trials. Honest answer: we didn't build sites where they live. FDA 2020: 75% of US trial participants were white. Research infrastructure clusters in the same zip codes. Geography first. Recruitment second. 19 Apr 2026 15:28 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mjubfkq4nr2hhttps://bsky.app/profile/william.maxoutput.ai/post/3mjrnubvqn72pTook myself out to the park before the next sprint kicked off. No phone. No Slack. Just trees and a longer walk than I'd planned. 18 Apr 2026 14:33 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mjrnubvqn72phttps://bsky.app/profile/william.maxoutput.ai/post/3mjpar2bqj72nPfizer paused. Moderna's next in line.17 Apr 2026 15:34 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mjpar2bqj72nhttps://bsky.app/profile/william.maxoutput.ai/post/3mjkgqdosfc2cNew in the newsletter: "When your I/E criteria disqualify the patients your trial is supposed to represent, that's not a recruitment problem. It's a protocol-design problem." Pfizer pause. AMRC 14→19. Daraxonrasib survival data. https://maxoutput.substack.com/p/pfizers-trial-didnt-fail-its-eligibility?r=6o81r515 Apr 2026 17:37 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mjkgqdosfc2chttps://bsky.app/profile/william.maxoutput.ai/post/3mji67quzs22c45-min prescreens that end in DQs cost your CRC's time, the patient's trust, and your site's conversion ratio. Build a 5-minute eligibility triage first. Protect the real calls. Site Sanity has the 5-step version: https://open.substack.com/pub/maxoutput/p/pfizers-trial-didnt-fail-its-eligibility?r=6o81r5&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true14 Apr 2026 20:00 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mji67quzs22chttps://bsky.app/profile/william.maxoutput.ai/post/3mjfya4mvnm2eIO Biotech filed Ch 7. Gossamer laid off 48%. Two Phase III failures in one week. Here's what nobody's saying: every one of those trials had CRCs running visits the morning the news hit. The hidden tax of biotech failure gets paid by sites that do the right thing when the money runs out. 13 Apr 2026 23:07 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mjfya4mvnm2ehttps://bsky.app/profile/william.maxoutput.ai/post/3mjdhehh5mk2zA coordinator needed to confirm one inclusion criterion before a screening visit. The protocol referenced another section. That referenced an appendix. The appendix referenced a scanned amendment. 1 question. 4 documents. 30 minutes. Patient waiting the whole time. #clinicalresearch 12 Apr 2026 23:00 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mjdhehh5mk2zhttps://bsky.app/profile/william.maxoutput.ai/post/3mja45y22jq2eMost of what matters compounds slowly. You do the work on Tuesday, and that work quietly pays you back every day after. The shortcuts look faster. They're not. 11 Apr 2026 15:01 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mja45y22jq2ehttps://bsky.app/profile/william.maxoutput.ai/post/3mj6ggzmff223Two weeks ago I posted about tier-one vs tier-two sites. This week CenExel made the case for me. Five site expansions. Psychedelic dosing rooms. Phase I inpatient units. CNS infrastructure. Specialized infrastructure is the moat. Tier one competes on price. #clinicalresearch 10 Apr 2026 23:00 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mj6ggzmff223https://bsky.app/profile/william.maxoutput.ai/post/3mj2q7axf2t2eNIH obligated $5.8B through March 20. That's 34% below the same point in FY24. New awards down 63%. Independent sites will feel this on a lag: quieter PI conversations in 90 days, narrower top-of-funnel in 6 months. Flag your NIH-linked protocols now. 09 Apr 2026 11:44 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mj2q7axf2t2ehttps://bsky.app/profile/william.maxoutput.ai/post/3miz6w5jaes2kApril is National Volunteer Month. Every patient in a clinical trial is a volunteer. Not a subject. Not a participant ID. The cost of every visit (parking, time, childcare, side effects) is absorbed by the volunteer. Every piece of friction in a protocol gets paid for by them.08 Apr 2026 21:02 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3miz6w5jaes2khttps://bsky.app/profile/william.maxoutput.ai/post/3mix4l5ri6k2lThe FDA just rewrote what counts as evidence three times since late Feb. Read which sponsors move first, and which of your current relationships are inside the shift. https://open.substack.com/pub/maxoutput/p/the-fda-changed-the-rules-three-times?r=6o81r5&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true08 Apr 2026 01:15 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mix4l5ri6k2lhttps://bsky.app/profile/william.maxoutput.ai/post/3mit6nwr3we2nYou'll spend $10K on patient recruitment and $15K on new software. But when your lead CRC asks for a raise, you "check the budget." Replacing them costs $50-60K. A $5K tuition benefit costs less than 10% of that. 06 Apr 2026 11:42 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mit6nwr3we2nhttps://bsky.app/profile/william.maxoutput.ai/post/3miqn6nhiha2lYou don't need to have it all figured out by Monday morning. Show up, do the next right thing, trust the rest will follow. That's always been enough. 05 Apr 2026 11:23 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3miqn6nhiha2lhttps://bsky.app/profile/william.maxoutput.ai/post/3mio4oxigjw2lThe people who changed your life probably don't know they did. A teacher, a stranger, a friend who checked in. You've been that person for someone too. Even if they never told you. 04 Apr 2026 11:23 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mio4oxigjw2lhttps://bsky.app/profile/william.maxoutput.ai/post/3mimexi4iak2qAdvocate Health launching 100,000 drone deliveries per year. Prescriptions, labs, supplies. Straight to patient doorsteps. When sponsors ask "can we deliver IP by drone?" the sites with compliant SOPs for chain-of-custody, temperature monitoring, and receipt verification will win those contracts.03 Apr 2026 18:46 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mimexi4iak2qhttps://bsky.app/profile/william.maxoutput.ai/post/3mij4p6pdds26FDA just made single-trial approval the standard. One pivotal study = one shot. Sponsors will select sites like they're drafting a championship team. Query rates, resolution times, deviation history. Quality isn't a nice-to-have anymore. It's your business model. 02 Apr 2026 11:40 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mij4p6pdds26https://bsky.app/profile/william.maxoutput.ai/post/3migmi62slu23ICON and Advarra just partnered to build a connected site network. If your site runs Advarra's stack, ICON sees your capacity in real time. No feasibility questionnaires. Your software just became a business development tool. The question: does your tech stack open doors or quietly close them? 01 Apr 2026 11:44 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3migmi62slu23https://bsky.app/profile/william.maxoutput.ai/post/3micphxriow2nIMA bought Chicago Research Center for its six-bed sleep lab and 50K patient database. That's infrastructure a network can't replicate overnight. Independent sites: the question is "what can we build that's hard to copy?" That's your moat. 30 Mar 2026 22:27 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3micphxriow2nhttps://bsky.app/profile/william.maxoutput.ai/post/3miaacxcqlc2rAldeyra got a Complete Response Letter from FDA for their dry eye drug. No more trials planned. Sites with this on their forecast just lost a revenue stream. Pipeline diversification across sponsor types and development phases is risk management, not growth strategy. #clinicalresearch29 Mar 2026 22:51 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3miaacxcqlc2rhttps://bsky.app/profile/william.maxoutput.ai/post/3mi55j27iea23CROs just got up to 75% faster at generating certain documentation. When protocols and amendments arrive at machine speed, coordinators still navigating 12 fragmented systems absorb all the pressure. Speed without capacity is just pressure. #clinicalresearch 28 Mar 2026 17:22 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mi55j27iea23https://bsky.app/profile/william.maxoutput.ai/post/3mi25k4r6vh26PE-backed networks are buying the middle class of the site ecosystem. Two site acquisitions: - PhaseWell bought Chase Medical Research. - IMA Group bought Chicago Research Center. Independent sites: specialize or form consortiums. The generalist middle ground is shrinking. 27 Mar 2026 12:45 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mi25k4r6vh26https://bsky.app/profile/william.maxoutput.ai/post/3mhxnq6slty23CMIC just cut clinical documentation time 75% with AI. The principle matters more than the tech: map the process, find where time disappears, place the tool there. I learned this the hard way building a hardware startup - process first, technology second. 26 Mar 2026 12:57 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mhxnq6slty23https://bsky.app/profile/william.maxoutput.ai/post/3mhuvo6clar23FDA issued 30 warning letters to telehealth companies selling compounded GLP-1s. As compounded supply tightens, patients may flow back to site-based clinical trials. Sites running obesity and cardiometabolic studies: update your recruitment messaging now. 25 Mar 2026 10:41 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mhuvo6clar23https://bsky.app/profile/william.maxoutput.ai/post/3mhtmg2jlbj2y7 open roles per 1 candidate?? 383 NIH trials halted, and what the sites keeping their people are doing differently. Quick read in this week's newsletter. https://maxoutput.substack.com/publish/post/191949667?r=6o81r5&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true 24 Mar 2026 22:22 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mhtmg2jlbj2yhttps://bsky.app/profile/william.maxoutput.ai/post/3mhq3uzcn6q2sCRCs managing studies now manage many different sponsor-mandated platforms. The tech reducing burden is creating new burden: platform fatigue. Negotiate a line item for training time. Protect your time. 23 Mar 2026 12:49 +0000at://did:plc:cua4be5nutffkvialimyrjny/app.bsky.feed.post/3mhq3uzcn6q2s